Skip to content

Comparison of Nasal Long Catheter Intubation versus Conventional Laryngeal Mask Airway in General Anesthesia for Electronic Bronchoscopy: A Prospective Randomized Controlled Trial

Comparison of Nasal Long Catheter Intubation versus Conventional Laryngeal Mask Airway in General Anesthesia for Electronic Bronchoscopy: A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106204
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-07-21
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

Laryngeal mask group (Group L):Place the laryngeal mask airway
Nasal long catheter group (Group N):Insert a long catheter (a disposable sterile suction catheter) into the trachea through the nose.

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. no gender limitation; 2. ASA grade II - III; 3.Age: 25-75 years old; 4. Before the inspection, the SpO2 should be =90% in the state of air inhalation and rest; 5.There are clear indications for the need to perform alveolar lavage under electronic bronchoscopy.

Exclusion criteria

Exclusion criteria: 1.Those who do not understand the test method or refuse to conduct the test; 2.The body mass index is greater than 28kg/m ^2; 3.Those with a history of allergy to propofol and opioid drugs and contraindications to their use; 4.Those with severe chronic diseases of the heart, liver, kidneys, etc., and abnormal blood coagulation function; 5.Patients with severe nasal obstruction, massive epistaxis, recent skull base surgery, severe intracranial hypertension and skull base fractures; 6.Those who are expected to have difficulty in mask ventilation, difficulty in placing laryngeal masks, and contraindications for their use; 7.People with mental disorders, anxiety disorders and depression.

Design outcomes

Primary

MeasureTime frame
Turnaround time (the time from the end of treatment to the patient entering the anesthesia recovery room;

Secondary

MeasureTime frame
The incidence and severity of hypoxemia;Dosage of opioid drugs;Dosage of propofol;Vital signs (heart rate, blood pressure, blood oxygen saturation);Exhaled carbon dioxide;Exhaled carbon dioxide;Incidence of adverse events;

Countries

China

Contacts

Public ContactCai Hongda

The First Affiliated Hospital of Fujian Medical University

caihd2000@163.com+86 139 5913 7859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026